demonstrated that secoisolariciresinol diglucoside (SDG) exerts its anti-CRC properties through inducing GSDMD-dependent pyroptosis through activation of the ROS/P13K/AKT/BAK-mitochondrial apoptosis pathway (93). This evidence concerns the gene GSDMD and colorectal carcinoma.